Wednesday, August 01, 2018 6:48:09 AM
buyout will come. to get full value company will have to demonstrate rms infusion products work in new market first. this is happening now and will continue. when i read the new ceo resume it is much more investor friendly and consequently rms will get the visibility it deserves. rms has been flying under the radar for a long time and this is about to change
One thing not talked about much is that the rms infusion devices have a superior flow profile. its more even flow rate throughout the infusion. its done at a lower pressure. And generally administered via smaller needle sizes which is important for patient comfort.
nice pop tuesday at end of day. could not find any news
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM